breast cancer
Conditions
Interventions
performing breast CT preoperatively
Sponsors
Grants for Scientific Research from the Expenses for Health and Welfare Program (17-7) from the Ministry of Health, Labour and Welfare of Japan
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Patients with histologically proven breast cancer, who were candidates for BCS as determined by palpation, MMG and US. 2) Patients without microcalcifications or with microcalcifications at most 2 cm away from the tumor). 3) Patients who provided written informed consent.
Exclusion criteria
Exclusion criteria: 1) Patients who have allergy to iodine containing contrast medium. 2) Patients who received neoadjuvant chemotherapy or endocrine therapy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The rate at which CT findings modified the planned surgical procedure, and whether or not it was effective. 1) If the newly identified region by CT included tumor in the pathological examination, the alteration was judged as effective. 2) If pathological examination revealed no tumor in the newly identified region, the alteration was evaluated as ineffective. | — |
Secondary
| Measure | Time frame |
|---|---|
| false negative detection false positive detection | — |
Countries
Japan
Contacts
Public ContactSadako Akashi-Tanaka
National Cancer Center Hospital, Tokyo, Japan Breast Surgery Division
Outcome results
None listed